About us and our objectives
Our vision for hospital pharmacy is set out in the revised Basel Statements on the future of hospital pharmacy. This document contains consensus statements by hospital pharmacists from around the world that were initially developed at the inaugural FIP Global Conference on the Future of Hospital Pharmacy in Basel, Switzerland, in 2008. Find out more about the Basel Statements here. To take a self-assessment survey of your hospital's pharmacy services compared to the Basel Statements please go to https://fiphsa.com.
The FIP Hospital Pharmacy Section Strategic Plan 2022-2027 to implement this vision can be found here.
FIP HPS strategic goals:
• Support, facilitate and enable sharing of resources for hospital pharmacy
• Set standards for hospital pharmacy practice and workforce (Basel Statements) underpinned by patient safety
• Focus on individual FIP members and FIP member organizations in all activities
• Focus on global needs (affecting all countries independent of levels of hospital pharmacy practice) while highlighting best practices in hospital pharmacy
We undertake many activities within the framework of our objectives and vision.
Follow us and our activities on social media: 
How we work
The Hospital Pharmacy Section’s Executive Committee (ExCo) consists of:
| President (2022-2026) Dr Ryan A. Forrey (USA) |
| Secretary (2021-2024) Dr Jonathan Penm (Australia) |
| Assistant secretary (2021-2024) Ms Christina Cella (Canada) |
| Treasurer (2022-2026) Dr John B. Hertig (USA) |
| Immediate past president (2022-2026) Mr Robert Moss (Netherlands) |
| Vice president - Africa (2022-2026) Mr Mujahid Valji (Tanzania) |
| Vice president - Western Pacific (2020-2024) Ms Chun-Yu (Mary) Wang (China Taiwan) |
| Vice president - Europe (2022-2026) Dr Josep M. Guiu-Segura (Spain) |
| Vice president - Japan (2022-2026) Prof. Yoshikazu Tasaki (Japan) |
| Vice president - The Americas (2022-2026) Dr Esteban Zavaleta (Costa Rica) |
| Vice president - Eastern Mediterranean (2022-2026) Dr Waël Abi Ghanem (Lebanon) |
| Vice president - Southeast Asia (2020-2024) Ms Yulia Trisna (Indonesia) |
|
|
|
2023-24 Hospital Pharmacy Section Executive Committee Back row, left to right: Mike Stepanovic, Stephen Eckel, Yoshikazu Tasaki, Robert Moss, Josep Guiu-Segura, John Hertig |
All members of the Hospital Pharmacy Section are eligible to be a member of the executive committee. All executive committee members are elected for four years and may be re-elected for one further four-year term. The president and the immediate past president normally only serve one four-year term.
Contact us at hps@fip.org
Click to download the HPS statutes in a pdf.
The Hospital Pharmacy Section also runs the following committees:
|
Basel Statements promotion committee |
|
Communications and digital committee
|
|
Finance committee
|
|
Research committee
|
|
Programme committee |
Research grants
We are delighted to report the outcomes of our past research grants.
Dr Moteehat Olubukola Olu-Lawal (Nigeria) conducted research on “Pharmaceutical care interventions: A tool for building interprofessional collaboration in two public healthcare institutions in Osun State.” The findings of this research are available in the final report here.
Dr Shania Liu (Australia) developed the “Pharmacist-Partnered Preoperative Opioid Tapering Resource Package”. This document serves as a resource package to support opioid tapering before elective hip or knee replacement surgery. The full resource is available here.
Dr Titilayo Abidemi Onedo (Nigeria) conducted research on “Strengthening Hospital Pharmacy Practice In Nigeria Through The Adoption And Implementation Of The Revised (2014) FIP Basel Statements”. The findings of this research are available in the final report here.
Annual reports
The HPS 2023 annual report is available here.
The HPS annual reports for 2020, 2021 and 2022 are also available.